The current explosion of new areas of controversy in the treatment of acute lymphocytic leukemia in adults and young adults makes this comprehensive book a much needed reference for hematologists and oncologists. Topics of discussion include indications for allogeneic bone marrow transplant in first complete remission, the treatment of your adults with ALL, the role of minimal residual disease in making treatment decisions, and the treatment of Philadelphia chromosome positive ALL with the advent of the tyrosine kinase inhibitors. The full spectrum of ALL subtypes and their treatments are covered. Focusing especially upon the adult ALL patient, this book is the first of its kind. It provides a complete overview of diagnosis, molecular pathogenesis, and treatment for this important patient population.